Destiny Pharma (DEST) RNS Announcements

Add to Alert list
Date Time Source Announcement
30 Nov 2020 02:00 PM
RNS
Holding(s) in Company
26 Nov 2020 10:50 AM
RNS
Result of General Meeting and Total Voting Rights
25 Nov 2020 07:00 AM
RNS
Result of Open Offer
09 Nov 2020 04:25 PM
RNS
Fundraising and Acquisition
12 Oct 2020 07:00 AM
RNS
Clinical Study Patient Recruitment Update
17 Sep 2020 07:00 AM
RNS
Interim results for the 6 months ended 30 Jun 2020
17 Sep 2020 07:00 AM
RNS
Update on Phase 2b clinical study of XF-73
10 Sep 2020 07:00 AM
RNS
Notice of Results
07 Sep 2020 04:40 PM
RNS
Second Price Monitoring Extn
07 Sep 2020 04:35 PM
RNS
Price Monitoring Extension
07 Sep 2020 02:06 PM
RNS
Second Price Monitoring Extn
07 Sep 2020 02:01 PM
RNS
Price Monitoring Extension
07 Sep 2020 11:06 AM
RNS
Second Price Monitoring Extn
07 Sep 2020 11:01 AM
RNS
Price Monitoring Extension
07 Sep 2020 09:05 AM
RNS
Second Price Monitoring Extn
07 Sep 2020 09:00 AM
RNS
Price Monitoring Extension
07 Sep 2020 07:00 AM
RNS
Collaboration to co-develop treatment for COVID-19
11 Aug 2020 07:00 AM
RNS
Positive interim safety review of XF-73 phase 2b
27 Jul 2020 07:00 AM
RNS
Update on Phase 2b clinical study of XF-73
15 Jul 2020 07:00 AM
RNS
Destiny Pharma notes launch of AMR Action Fund
19 Jun 2020 11:00 AM
RNS
Cancellation and Grant of Options
10 Jun 2020 12:30 PM
RNS
Result of AGM
09 Jun 2020 07:00 AM
RNS
Grant awarded for Cardiff University collaboration
12 May 2020 03:15 PM
RNS
Posting of Annual Report and Notice of AGM
04 May 2020 07:00 AM
RNS
Independent review supports the potential of XF-73
29 Apr 2020 07:00 AM
RNS
Final Results
24 Apr 2020 07:00 AM
RNS
Notice of Results
03 Mar 2020 07:00 AM
RNS
Clinical and Business Update
20 Jan 2020 07:00 AM
RNS
Update on the development of XF drug formulations
17 Dec 2019 07:00 AM
RNS
APSIC guidelines recommend decolonising S. aureus
02 Dec 2019 07:00 AM
RNS
Directorate Change
02 Dec 2019 07:00 AM
RNS
Destiny to present at UK-China AMR Workshop
15 Nov 2019 07:30 AM
RNS
Presentation at the Investival Showcase
06 Nov 2019 07:00 AM
RNS
Destiny Pharma to present at World AMR Congress
16 Oct 2019 07:00 AM
RNS
Positive phase 1 results published in journal
23 Sep 2019 07:00 AM
RNS
Directorate Change
23 Sep 2019 07:00 AM
RNS
Interim Results for 6 months ended 30 June 2019
12 Sep 2019 07:00 AM
RNS
Notice of Results
10 Sep 2019 07:00 AM
RNS
University of Sheffield Research Collaboration
02 Sep 2019 07:00 AM
RNS
XF Drug platform data presented at EuroBiofilms
15 Aug 2019 12:20 PM
RNS
Holding(s) in Company
31 Jul 2019 07:00 AM
RNS
Presentation at Gordon Research Conference
19 Jul 2019 03:12 PM
RNS
Holding(s) in Company
04 Jun 2019 02:39 PM
RNS
Grant of Options
04 Jun 2019 12:06 PM
RNS
Result of AGM
09 May 2019 02:06 PM
RNS
Appointment of NOMAD and Joint Broker
29 Apr 2019 02:28 PM
RNS
Posting of Annual Report and Notice of AGM
09 Apr 2019 07:00 AM
RNS
Final Results
05 Apr 2019 05:06 PM
RNS
Exercise of Options
01 Apr 2019 03:03 PM
RNS
Exercise of Options
UK 100

Latest directors dealings